Q2 2025 · 13F-HR
Rubric Capital Management LPholdings as filed
Filed 2025-08-14 · accession 0001104659-25-078662
$6.62B
Reported value
66
Positions
2025-06-30
Period end
The Brief · Rubric Capital Management LP · Q2 2025
AI · grounded in 13F
Rubric Capital Management LP established a new position in TLN valued at $1.31B. The fund also initiated new stakes in TEVA for $435.76M and FTAI for $390.45M. Additional new positions include GLNG at $378.08M and VST at $276.14M. Total assets under management stand at $6.62B across 66 positions.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 87422Q109 | TLN | TALEN ENERGY CORP | $1.31B | 19.8% | 4,505,302 | Common | SOLE |
| 881624209 | TEVA | TEVA PHARMACEUTICAL INDS LTD | $435.8M | 6.58% | 26,000,000 | Common | SOLE |
| G3730V105 | FTAI | FTAI AVIATION LTD | $390.5M | 5.90% | 3,394,080 | Common | SOLE |
| G9456A100 | GLNG | GOLAR LNG LTD | $378.1M | 5.71% | 9,178,978 | Common | SOLE |
| 92840M102 | VST | VISTRA CORP | $276.1M | 4.17% | 1,424,803 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $229.6M | 3.47% | 20,370,336 | Common | SOLE |
| 343412102 | FLR | FLUOR CORP NEW | $205.1M | 3.10% | 4,000,000 | Common | SOLE |
| 088929104 | BGC | BGC GROUP INC | $174.0M | 2.63% | 17,005,582 | Common | SOLE |
| 89346D107 | TAC | TRANSALTA CORP | $172.1M | 2.60% | 15,948,451 | Common | SOLE |
| 78464A870 | XBI | SPDR SERIES TRUST | $165.9M | 2.51% | 2,000,000 | PUT | SOLE |
| 03969K108 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | $150.7M | 2.28% | 10,749,457 | Common | SOLE |
| 589400100 | MCY | MERCURY GENL CORP NEW | $138.4M | 2.09% | 2,054,504 | Common | SOLE |
| 88160R101 | TSLA | TESLA INC | $136.6M | 2.06% | 430,000 | PUT | SOLE |
| 219798105 | QDEL | QUIDELORTHO CORP | $133.7M | 2.02% | 4,637,738 | Common | SOLE |
| 01626W101 | ALIT | ALIGHT INC | $111.1M | 1.68% | 19,626,953 | Common | SOLE |
| G52694109 | KNSA | KINIKSA PHARMACEUTICALS INTL | $108.2M | 1.63% | 3,909,806 | Common | SOLE |
| 92556V106 | VTRS | VIATRIS INC | $107.2M | 1.62% | 12,000,000 | Common | SOLE |
| 80810D103 | SDGR | SCHRODINGER INC | $100.6M | 1.52% | 5,000,000 | Common | SOLE |
| G7500M104 | RNW | RENEW ENERGY GLOBAL PLC | $99.8M | 1.51% | 14,438,061 | Common | SOLE |
| 433000106 | HIMS | HIMS & HERS HEALTH INC | $99.7M | 1.51% | 2,000,000 | PUT | SOLE |
| 03168L105 | AMRX | AMNEAL PHARMACEUTICALS INC | $94.7M | 1.43% | 11,710,332 | Common | SOLE |
| 19459J104 | COLL | COLLEGIUM PHARMACEUTICAL INC | $93.4M | 1.41% | 3,157,743 | Common | SOLE |
| 457985208 | IART | INTEGRA LIFESCIENCES HLDGS C | $90.2M | 1.36% | 7,353,934 | Common | SOLE |
| M85548101 | SSYS | STRATASYS LTD | $89.5M | 1.35% | 7,803,097 | Common | SOLE |
| 644393100 | NFE | NEW FORTRESS ENERGY INC | $81.0M | 1.22% | 24,400,000 | Common | SOLE |
| 00650F109 | ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $72.9M | 1.10% | 6,256,847 | Common | SOLE |
| G4766E116 | INDV | INDIVIOR PLC | $68.5M | 1.03% | 4,647,179 | Common | SOLE |
| 68375N103 | OPK | OPKO HEALTH INC | $63.1M | 0.95% | 47,791,243 | Common | SOLE |
| 00676P107 | ADEA | ADEIA INC | $60.6M | 0.92% | 4,284,205 | Common | SOLE |
| 98985Y108 | ZYME | ZYMEWORKS INC | $59.1M | 0.89% | 4,710,551 | Common | SOLE |
| G61188101 | LBTYA | LIBERTY GLOBAL LTD | $57.0M | 0.86% | 5,692,225 | Common | SOLE |
| 24665A103 | DK | DELEK US HLDGS INC NEW | $56.9M | 0.86% | 2,687,449 | Common | SOLE |
| 427746102 | HRTX | HERON THERAPEUTICS INC | $55.3M | 0.84% | 26,713,503 | Common | SOLE |
| 62482R107 | 07WA | MR COOPER GROUP INC | $50.4M | 0.76% | 337,924 | Common | SOLE |
| 69331C108 | PCG | PG&E CORP | $50.2M | 0.76% | 3,600,000 | Common | SOLE |
| 89532M101 | TRVI | TREVI THERAPEUTICS INC | $46.7M | 0.70% | 8,531,860 | Common | SOLE |
| 13765N107 | CNNE | CANNAE HLDGS INC | $43.9M | 0.66% | 2,105,864 | Common | SOLE |
| 68752M108 | OFIX | ORTHOFIX MED INC | $41.5M | 0.63% | 3,721,715 | Common | SOLE |
| 589492107 | MREO | MEREO BIOPHARMA GROUP PLC | $41.5M | 0.63% | 15,307,347 | Common | SOLE |
| 743713109 | PRLB | PROTO LABS INC | $41.4M | 0.63% | 1,034,171 | Common | SOLE |
| 27923Q109 | ECVT | ECOVYST INC | $38.7M | 0.59% | 4,707,347 | Common | SOLE |
| G61188127 | LBTYK | LIBERTY GLOBAL LTD | $33.9M | 0.51% | 3,289,789 | Common | SOLE |
| 98423J101 | XPER | XPERI INC | $32.8M | 0.50% | 4,143,744 | Common | SOLE |
| 36162J106 | GEO | GEO GROUP INC NEW | $29.9M | 0.45% | 1,247,393 | Common | SOLE |
| 808541106 | MATV | MATIV HOLDINGS INC | $27.2M | 0.41% | 3,982,442 | Common | SOLE |
| G2143T103 | CMPR | CIMPRESS PLC | $26.4M | 0.40% | 561,429 | Common | SOLE |
| 45828L108 | IAS | INTEGRAL AD SCIENCE HLDNG CO | $24.7M | 0.37% | 2,971,951 | Common | SOLE |
| G59665102 | MGTX | MEIRAGTX HLDGS PLC | $24.3M | 0.37% | 3,726,451 | Common | SOLE |
| 82835W108 | SPRY | ARS PHARMACEUTICALS INC | $22.6M | 0.34% | 1,294,878 | Common | SOLE |
| 868459108 | SUPN | SUPERNUS PHARMACEUTICALS INC | $21.9M | 0.33% | 695,039 | Common | SOLE |
| 879512309 | TSAT | TELESAT CORP | $20.6M | 0.31% | 843,781 | Common | SOLE |
| 21037T109 | CEG | CONSTELLATION ENERGY CORP | $17.6M | 0.27% | 54,507 | Common | SOLE |
| 810648105 | SCPH | SCPHARMACEUTICALS INC | $17.5M | 0.26% | 4,601,977 | Common | SOLE |
| 488445206 | ZVRA | ZEVRA THERAPEUTICS INC | $17.3M | 0.26% | 1,958,318 | Common | SOLE |
| 21871N101 | CXW | CORECIVIC INC | $17.2M | 0.26% | 815,280 | Common | SOLE |
| 00182C103 | ANIP | ANI PHARMACEUTICALS INC | $16.8M | 0.25% | 257,669 | Common | SOLE |
| 87615L107 | TH | TARGET HOSPITALITY CORP | $15.6M | 0.24% | 2,189,456 | Common | SOLE |
| 812215200 | SEG | SEAPORT ENTMT GROUP INC | $10.6M | 0.16% | 568,530 | Common | SOLE |
| 29082K105 | EMBC | EMBECTA CORP | $10.1M | 0.15% | 1,037,416 | Common | SOLE |
| 03879J100 | ABUS | ARBUTUS BIOPHARMA CORP | $4.9M | 0.07% | 1,575,376 | Common | SOLE |
| 72815G108 | MYPS | PLAYSTUDIOS INC | $3.5M | 0.05% | 2,697,384 | Common | SOLE |
| 68375NAG8 | OPK 3.75 01/15/29 | OPKO HEALTH INC | $1.7M | 0.03% | 1,250,000 | Common | SOLE |
| 27966L306 | EDSA | EDESA BIOTECH INC | $1.4M | 0.02% | 687,500 | Common | SOLE |
| 88338N206 | TXMD | THERAPEUTICSMD INC | $1.4M | 0.02% | 1,192,191 | Common | SOLE |
| 19249H103 | CHRS | COHERUS ONCOLOGY INC | $634,622 | 0.01% | 867,800 | Common | SOLE |
| 690469101 | OVID | OVID THERAPEUTICS INC | $157,868 | 0.00% | 478,533 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.